The Development of Preventives and Therapeutics for Alzheimer's Disease that Inhibit the Formation of &bgr;-Amyloid Fibrils (fA&bgr;), as Well as Destabilize Preformed fA&bgr;

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|33|4357-4375

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.33, 2006-11, pp. : 4357-4375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of &bgr;-Amyloid Protein in Synaptic Function: Implications for Alzheimer's Disease Therapy

By  

Current Neuropharmacology, Vol. 4, Iss. 2, 2006-04 ,pp. : 149-163

Bentham Science Publishers

Access to resources Recommend Favorite

Fluorine-18 Radiolabeled Heterocycles as PET Tracers for Imaging &bgr;- Amyloid Plaques in Alzheimer’s Disease

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 8, 2013-04 ,pp. : 909-919

Bentham Science Publishers

Access to resources Recommend Favorite

Intracellular Amyloid &bgr;-Protein and Its Associated Molecules in the Pathogenesis of Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 10, 2006-10 ,pp. : 1075-1080

Bentham Science Publishers

Access to resources Recommend Favorite

The Amyloid &bgr;-Protein Precursor and Alzheimer's Disease. Therapeutic Approaches

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 4, 2005-12 ,pp. : 271-283

Bentham Science Publishers

Access to resources Recommend Favorite

Arrest of Amyloid Fibril Formation Associated to Type II Diabetes: Structural and Functional Links to the Mechanism of Alzheimer's &bgr;- Amyloid Fibrillization

By  

Drug Design Reviews - Online, Vol. 2, Iss. 2, 2005-01 ,pp. : 115-119

Bentham Science Publishers

Access to resources Recommend Favorite